文献速递认知障碍与痴呆

慢性创伤性脑损伤中的β-淀粉样蛋白与tau蛋白成像:一项横断面研究

β-Amyloid and Tau Imaging in Chronic Traumatic Brain Injury: A Cross-sectional Study.
PubMed 文献 · Neurology · 2022-06-15

该横断面研究纳入至少10年前发生单次中重度创伤性脑损伤(TBI)的87例患者和59名健康对照,采用18F-NAV4694(Aβ)和18F-MK6240(tau)PET成像评估慢性期Aβ与tau负荷。结果显示TBI患者Aβ Centiloid值未显著高于对照(p=0.067),各感兴趣区tau SUVR均不高于对照(p≤0.001,对照更高),且Aβ或tau负荷与伤后时间或受伤年龄无显著关联。

要点

  • 单次中重度TBI后慢性期Aβ与tau负荷未显著高于健康对照。
  • TBI患者Aβ或tau负荷与伤后时间、受伤年龄无显著关联。
  • 视觉评估与定量结果一致,TBI患者Aβ或tau阳性率未显著高于对照。

核心结论

  • 单次中重度TBI在慢性期与健康对照相比未伴随更高的Aβ或tau病理负荷。
  • Aβ和tau负荷未随伤后年数显著增加,受伤时年龄较大者负荷似乎也不更高。

研究设计与样本

  • 采用横断面设计,从住院康复项目中招募至少10年前发生单次中重度TBI的个体。
  • 从社区招募人口学特征相似的健康对照组。
  • 使用18F-NAV4694(Aβ)和18F-MK6240(tau)示踪剂获取PET数据。
  • Aβ沉积用Centiloid量表定量,tau沉积用4个感兴趣区的标准化摄取值比(SUVR)定量。
  • 作为次要指标,PET扫描也进行阳性或阴性的视觉判读。

主要发现

  • 样本包括87例TBI患者(男性71.3%,女性28.7%;平均57.53岁,SD 11.53)和59名对照(男性59.3%,女性40.7%;平均60.34岁,SD 11.97)。
  • TBI患者的18F-NAV4694 Centiloid值未显著更高(p=0.067)。
  • TBI患者各感兴趣区的18F-MK6240 tau SUVR均不更高(p≤0.001;对照的SUVR更高)。
  • 视觉评估与定量一致:TBI患者Aβ阳性扫描的可能性未高于对照(p=0.505),tau阳性扫描的可能性也未高于对照(p=0.221)。
  • Aβ或tau负荷与伤后时间(p=0.057至0.332)或受伤年龄无显著关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Traumatic brain injury (TBI) has been promoted as a risk factor for Alzheimer disease (AD). There is evidence of elevated β-amyloid (Aβ) and tau, the pathologic hallmarks of AD, immediately following TBI. It is not clear whether Aβ and tau remain elevated in the chronic period. To address this issue, we assessed Aβ and tau burden in long-term TBI survivors and healthy controls using PET imaging. METHODS: Using a cross-sectional design, we recruited individuals following a single moderate to severe TBI at least 10 years previously from an inpatient rehabilitation program. A demographically similar healthy control group was recruited from the community. PET data were acquired using 18F-NAV4694 (Aβ) and 18F-MK6240 (tau) tracers. Aβ deposition was quantified using the Centiloid scale. Tau deposition was quantified using the standardized uptake value ratio (SUVR) in 4 regions of interest (ROIs). As a secondary measure, PET scans were also visually read as positive or negative. We examined PET data in relation to time since injury and age at injury. PET data were analyzed in a series of regression analyses. RESULTS: The sample comprised 87 individuals with TBI (71.3% male; 28.7% female; mean 57.53 years, SD 11.53) and 59 controls (59.3% male; 40.7% female; mean 60.34 years, SD 11.97). Individuals with TBI did not have significantly higher 18F-NAV4694 Centiloid values (p = 0.067) or 18F-MK6240 tau SUVRs in any ROI (p ≤ 0.001; SUVR greater for controls). Visual assessment was consistent with the quantification; individuals with TBI were not more likely than controls to have a positive Aβ (p = 0.505) or tau scan (p = 0.221). No associations were identified for Aβ or tau burden with time since injury (p = 0.057 to 0.332) or age at injury. DISCUSSION: A single moderate to severe TBI was not associated with higher burden of Aβ or tau pathologies in the chronic period relative to healthy controls. Aβ and tau burden did not show a significant increase with years since injury, and burden did not appear to be greater for those who were older at the time of injury.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Hicks AJ, Ponsford JL, Spitz G, et al. β-Amyloid and Tau Imaging in Chronic Traumatic Brain Injury: A Cross-sectional Study. Neurology. 2022. PMID: 36096678. doi:10.1212/WNL.0000000000200857

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。